Literature DB >> 24248354

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.

David Skurnik1, Damien Roux, Vincent Cattoir, Olga Danilchanka, Xi Lu, Deborah R Yoder-Himes, Kook Han, Thomas Guillard, Deming Jiang, Charlotte Gaultier, François Guerin, Hugues Aschard, Roland Leclercq, John J Mekalanos, Stephen Lory, Gerald B Pier.   

Abstract

An important question regarding the biologic implications of antibiotic-resistant microbes is how resistance impacts the organism's overall fitness and virulence. Currently it is generally thought that antibiotic resistance carries a fitness cost and reduces virulence. For the human pathogen Pseudomonas aeruginosa, treatment with carbapenem antibiotics is a mainstay of therapy that can lead to the emergence of resistance, often through the loss of the carbapenem entry channel OprD. Transposon insertion-site sequencing was used to analyze the fitness of 300,000 mutants of P. aeruginosa strain PA14 in a mouse model for gut colonization and systemic dissemination after induction of neutropenia. Transposon insertions in the oprD gene led not only to carbapenem resistance but also to a dramatic increase in mucosal colonization and dissemination to the spleen. These findings were confirmed in vivo with different oprD mutants of PA14 as well as with related pairs of carbapenem-susceptible and -resistant clinical isolates. Compared with OprD(+) strains, those lacking OprD were more resistant to killing by acidic pH or normal human serum and had increased cytotoxicity against murine macrophages. RNA-sequencing analysis revealed that an oprD mutant showed dramatic changes in the transcription of genes that may contribute to the various phenotypic changes observed. The association between carbapenem resistance and enhanced survival of P. aeruginosa in infected murine hosts suggests that either drug resistance or host colonization can cause the emergence of more pathogenic, drug-resistant P. aeruginosa clones in a single genetic event.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24248354      PMCID: PMC3870709          DOI: 10.1073/pnas.1221552110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The biological cost of mutational antibiotic resistance: any practical conclusions?

Authors:  Dan I Andersson
Journal:  Curr Opin Microbiol       Date:  2006-08-04       Impact factor: 7.934

2.  Fitness and dissemination of disinfectant-selected multiple-antibiotic-resistant (MAR) strains of Salmonella enterica serovar Typhimurium in chickens.

Authors:  Luke P Randall; M C Bagnall; K A Karatzas; Nick C Coldham; Laura J V Piddock; Martin J Woodward
Journal:  J Antimicrob Chemother       Date:  2007-11-12       Impact factor: 5.790

3.  Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays.

Authors:  Wagner R Montor; Jin Huang; Yanhui Hu; Eugenie Hainsworth; Susan Lynch; Jeannine-Weiner Kronish; Claudia L Ordonez; Tanya Logvinenko; Stephen Lory; Joshua LaBaer
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

4.  Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.

Authors:  Daniel J Wolter; Dee Acquazzino; Richard V Goering; Paul Sammut; Noha Khalaf; Nancy D Hanson
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

5.  Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.

Authors:  Didier Hocquet; Philippe Berthelot; Micheline Roussel-Delvallez; Roger Favre; Katy Jeannot; Odile Bajolet; Nicole Marty; Florence Grattard; Patricia Mariani-Kurkdjian; Edouard Bingen; Marie-Odile Husson; Gérard Couetdic; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

6.  Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung.

Authors:  Jeffrey D Gawronski; Sandy M S Wong; Georgia Giannoukos; Doyle V Ward; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

7.  Identifying genetic determinants needed to establish a human gut symbiont in its habitat.

Authors:  Andrew L Goodman; Nathan P McNulty; Yue Zhao; Douglas Leip; Robi D Mitra; Catherine A Lozupone; Rob Knight; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2009-09-17       Impact factor: 21.023

8.  Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments.

Authors:  Emma L McConnell; Abdul W Basit; Sudaxshina Murdan
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

9.  Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial.

Authors:  Daniel G Lee; Jonathan M Urbach; Gang Wu; Nicole T Liberati; Rhonda L Feinbaum; Sachiko Miyata; Lenard T Diggins; Jianxin He; Maude Saucier; Eric Déziel; Lisa Friedman; Li Li; George Grills; Kate Montgomery; Raju Kucherlapati; Laurence G Rahme; Frederick M Ausubel
Journal:  Genome Biol       Date:  2006-10-12       Impact factor: 13.583

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  49 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  High-throughput, Highly Sensitive Analyses of Bacterial Morphogenesis Using Ultra Performance Liquid Chromatography.

Authors:  Samantha M Desmarais; Carolina Tropini; Amanda Miguel; Felipe Cava; Russell D Monds; Miguel A de Pedro; Kerwyn Casey Huang
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 3.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

4.  Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Authors:  Magnus Paulsson; Birendra Singh; Tamim Al-Jubair; Yu-Ching Su; Niels Høiby; Kristian Riesbeck
Journal:  J Cyst Fibros       Date:  2015-06-03       Impact factor: 5.482

5.  Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Authors:  Marta Putrinš; Karin Kogermann; Eliisa Lukk; Markus Lippus; Vallo Varik; Tanel Tenson
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

Review 6.  ESKAPEing the labyrinth of antibacterial discovery.

Authors:  Ruben Tommasi; Dean G Brown; Grant K Walkup; John I Manchester; Alita A Miller
Journal:  Nat Rev Drug Discov       Date:  2015-07-03       Impact factor: 84.694

Review 7.  Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

8.  Uncoupled Quorum Sensing Modulates the Interplay of Virulence and Resistance in a Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolate Belonging to the MLST550 Clonal Complex.

Authors:  Tingying Xia; Yanran Li; Zeling Xu; Huiluo Cao; Salim Bougouffa; Yat Kei Lo; Vladimir B Bajic; Haiwei Luo; Patrick C Y Woo; Aixin Yan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

9.  Comparison of inherently essential genes of Porphyromonas gingivalis identified in two transposon-sequencing libraries.

Authors:  J A Hutcherson; H Gogeneni; D Yoder-Himes; E L Hendrickson; M Hackett; M Whiteley; R J Lamont; D A Scott
Journal:  Mol Oral Microbiol       Date:  2015-10-23       Impact factor: 3.563

10.  Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae.

Authors:  David Skurnik; Damien Roux; Stephanie Pons; Thomas Guillard; Xi Lu; Colette Cywes-Bentley; Gerald B Pier
Journal:  J Antimicrob Chemother       Date:  2016-01-07       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.